Volume 26, Issue 128, October 2022

The rife self-confessed disorders associated with hormonal contraceptives

Ebtehaj Saud ALmughais¹, Fatmah Fahad Alreshidi¹, Rana Aboras², Rasha Alarfaj³, Samiah Ahmed Almehmadi⁴, Maram ALmohammadi⁵, Maha Mohammad ALSugair⁶, Hella O. AlOthman⁷, Afag Altigani Ali⁸, Aya Alsedig Ali⁸, Samah Batran⁸, Hussain Gadelkarim Ahmed^8♦

¹Department of Family and Community Medicine, College of Medicine, University of Hail, Hail, Saudi Arabia
²Department of Community Medicine, College of Medicine, University of Hail, Ha’il 55476, Saudi Arabia
³Department of Family and Community Medicine, Unaizah College of Medicine and Medical sciences, Qassim University, Unaizah, Kingdom of Saudi Arabia
⁴Consultant family medicine, Lifestyle medicine specialist, Ministry of Health, Hail Health cluster, Hail, Saudi Arabia
⁵Consultant Family medicine, Tabuk health cluster, Department of Family Medicine, MOH, Saudi Arabia ⁶Family medicine department, King Fahad Armed Forces Hospital, Jeddah, kingdom of Saudi Arabia
⁷Associate consultant in Family medicine, King Abdulaziz Medical City, National Guard, Family Medicine department, Saudi Arabia
⁸Department of Histopathology and Cytology, FMLS, University of Khartoum, Sudan

^♦Corresponding author
Department of Histopathology and Cytology, FMLS, University of Khartoum, Sudan

ABSTRACT

Background: The side effects of hormonal contraceptives (HCs) vary greatly between women, and different HCs cause distinct side effects. This study aimed to assess the rife of self-confessed disorders associated with hormonal contraceptives. Methodology: The study enrolled 200 ladies of reproductive age. One hundred women were HCs users (ascertained as cases) and 100 women non-contraceptives users (ascertained as a control group). Results: Irregular menstrual cycles were observed in 29% of the cases and 28% of the controls. In 21% of cases, the duration of menstruation recycling was unpredictable, compared to 26% in controls. Hormonal abnormalities were more common among controls than among cases. The hormonal associated problems in controls were: OR (95%CI) = 2.5550(1.1753 to 5.5545), P-value = 0.0179. The risk of recurrent infection among control group was OR (95%CI) = 1.5952 (0.8984 to 2.8326), P = 0.1109. Conclusion: The current study revealed no statistically significant differences in hormonal contraceptive-related illnesses between HCs users and non-users.

Keywords: hormonal contraceptive, birth pills, women, menstrual cycle

Medical Science, 2022, 26, ms413e2488

PDF

DOI: https://doi.org/10.54905/disssi/v26i128/ms413e2488

Published: 15 October 2022